Monitoring serum vancomycin concentrations in children: Is it necessary?

Pediatric Infectious Disease Journal

Volumn 17, Issue 4, 1998, Pages 351-353

  Thomas, Mathew P ^a   Steele, Russell W ^a,b  

^a CHILDREN S HOSPITAL   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Monitoring; Vancomycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BURETROL; CREATININE CLEARANCE; DIAGNOSTIC APPROACH ROUTE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MONITORING; HUMAN; HUMAN CELL; HUMAN TISSUE; NEPHROTOXICITY; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADOLESCENT; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; LOUISIANA; MALE; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 0031969284     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199804000-00020     Document Type: Article

References (13)

1. Cantu TG, Yamanaka-Yuen NA, Lietman PS. Serum vancomycin concentrations: reappraisal of their clinical value. Clin Infect Dis 1994;18:533-43.
2. Mollering RC Jr. Monitoring serum vancomycin levels: climbing the mountain because it is there? [Editorial]. Clin Infect Dis 1994;18:544-6.
3. Saunders NJ. Why monitor peak vancomycin concentrations? Lancet 1994;344:1748-50.
4. Ena J, Dick RW, Jones RN, et al. The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA 1993;269:598-602.
5. Schaad UB, Nelson JD, McCracken GH Jr. Pharmacology and efficacy of vancomycin for staphylococcal infections in children. Rev Infect Dis 1981;3(Suppl):S282-8.
6. Chang D, Liem L, Malogolowkin M. A prospective of vancomycin pharmokinetics and dosage requirements in pediatric cancer patients. Pediatr Infect Dis J 1994;13:969-74.
7. Schaad UB, McCracken GH Jr., Nelson JD. Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr 1980;96:119-26.
8. Schaible DH, Rocci ML, Alpert GA, et al. Vancomycin pharmacokinetics in infants: relationships to indices of maturation. Pediatr Infect Dis J 1986;5:304-8.
9. Wold JS, Turnipseed SA. Toxicology of vancomycin in laboratory animals. Rev Infect Dis 1981;3(Suppl):S224-9.
10. Spears RL, Koch R. The use of vancomycin in pediatrics. Antibiot Annu 1959-1960:98-803.
11. Geraci JE, Heilman FR, Nichols DR, et al. Antibiotic therapy of bacterial endocarditis: VII. Vancomycin for acute micrococcal endocarditis: preliminary report. Mayo Clin Proc 1958;33: 172-81.
12. Aronoff GR, Sloan RS, Dinwiddie CB Jr., et al. Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother 1981;19:306-8.
13. Leader WG, Chandler MHH, Castiglia M. Pharmacokinetic optimisation of vancomycin therapy. Clin Pharmacokinet 1995;28:327-42.